Role of Oxidative Stress and Antioxidants in Women’s Reproductive and Sexual Health

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Sex, Gender and Hormone Based Medicine".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 587

Special Issue Editor


E-Mail Website
Guest Editor
Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia
Interests: oxidative stress; PCOS; antioxidants; cardiometabolic risk; metabolic syndrome; hormone disbalance; phytotherapy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Some physiological processes depend on the formation of reactive oxygen species (ROS), which enables and ensures that the cells and tissues are operating in a homeostatic environment. However, oxidative stress occurs due to increased levels of ROS and/or a weakened antioxidative potential. ROS are involved in a plethora of biological effects, participating in the pathogenesis of an increasing number of diseases, thus identifying the biomarkers of oxidative stress could be of importance in prevention as well as therapy of various diseases. Moreover, it is known that oxidative stress levels vary between genders and depend on hormone-related alterations. Reproductive and sexual health are dependent on global redox homeostasis, but research data on the role of antioxidants in the prevention and treatment of oxidative stress-related pathologies in women are conflicting. Starting with reproductive endocrine disorders such as polycystic ovary syndrome (PCOS), progressing to pregnancy-related disorders such as preeclampsia and gestational diabetes mellitus (GDM), and ending with the loss of estrogen-protective roles in menopause, women’s organisms are highly vulnerable to oxidative stress. Accordingly, many antioxidative molecules have been investigated, and their beneficial effects have been proven in many translational, preclinical, and clinical studies. Although concerns about their safety in the pre-gestational and gestational period remain elusive, various nutraceutical and pharmaceutical interventions have been carried out to ameliorate oxidative stress in women. Potential topics include but are not limited to the role of oxidative stress and antioxidants in PCOS, endometriosis, preeclampsia, GDM, intrauterine growth retardation, preterm birth, women's sexual dysfunction, inflammatory processes of women’s genital organs, and similar entities. In addition to the basic science to clinical translational work that is fundamental to uncovering the complex relationship between oxidative stress and reproductive pathophysiology, this Special Issue highlights the importance of recognizing the known and potentially novel biomarkers of oxidative stress in different pathologies related to reproductive and sexual health.

Original and review articles (including experiments on animals or human studies) addressing these topics are invited for this Special Issue, which is focused on the determination of oxidative stress biomarkers in reproductive and sexual disorders in women as well as the role of antioxidants in mitigating pathophysiological disturbances and exhibiting preventive or therapeutic potential. 

Dr. Jovana Joksimovic Jovic
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • antioxidants
  • women
  • PCOS
  • endometriosis
  • gestational diabetes mellitus
  • preeclampsia
  • sexual dysfunction
  • preterm birth
  • menopause

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop